title: A report from the 2011 annual meeting of the american academy of Allergy, Asthma and Immunology (March 18-22, 2011 - San Francisco, California, USA).
abstract: San Francisco held this year's annual meeting of the American Academy of Allergy, Asthma and Immunology at the Moscone Center, where oral and poster sessions, educational courses and informal discussions called to the mind of attendees important news on a wide range of topics, including the main subject of this report: therapies for immune-based disorders as common as asthma or allergic rhinoconjunctivitis. A lot of important news from clinical and preclinical studies was disclosed to specialists attending this year's meeting. Most of the new research directly related to therapy for immunological diseases and disorders is summarized in the following report.
authors.affiliation: Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com
authors.forename: X
authors.initials: X
authors.lastname: Rabasseda
mesh_terms: D000486:Allergy and Immunology; D000799:Angioedema / Q000628:therapy; D001249:Asthma / Q000628:therapy*; D003233:Conjunctivitis, Allergic / Q000628:therapy; D003876:Dermatitis, Atopic / Q000628:therapy; D005512:Food Hypersensitivity / Q000628:therapy; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D007154:Immune System Diseases; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy